1.
Cancer cell
; 2023.
Article
in English
| Europe PMC | ID: covidwho-2240455
2.
Cancer Cell
; 41(4): 649-650, 2023 04 10.
Article
in English
| MEDLINE | ID: covidwho-2229688
ABSTRACT
Ehmsen et al. evaluate the neutralizing capacity to current SARS-CoV-2 variants in patients with cancer before and after receiving the BNT162b2 bivalent mRNA vaccine booster. Bivalent vaccine provides some protection against BQ.1.1 but fails to protect against XBB.1 and XBB.1.5 in patients with cancer.
Subject(s)
COVID-19 , Neoplasms , Humans , COVID-19/prevention & control , SARS-CoV-2/genetics , BNT162 Vaccine , Neoplasms/genetics , Neoplasms/therapy , RNA, Messenger/genetics
3.
Cancer Cell
; 40(4): 338-339, 2022 04 11.
Article
in English
| MEDLINE | ID: covidwho-1926255
Subject(s)
COVID-19 , Neoplasms , Antibody Formation , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Neoplasms/genetics , RNA, Messenger , Vaccination
4.
Cancer Cell
; 40(8): 800-801, 2022 08 08.
Article
in English
| MEDLINE | ID: covidwho-1914203
Subject(s)
COVID-19 , Neoplasms , COVID-19/prevention & control , COVID-19 Vaccines , Humans , RNA, Messenger , Vaccination
5.
Cancer Cell
; 39(8): 1034-1036, 2021 08 09.
Article
in English
| MEDLINE | ID: covidwho-1330678